Clinical trial

SKB264 in Combination With SKB118 for Non-Small Cell Lung Cancer

NCT07697586

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-08-07

PhasePHASE2

Study timeline

Study start (actual)2026-08-07Date precision: day

Registry last updated2026-08-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

NSCLCunresolved

Interventions

SKB264+SKB118DRUG

Sponsors & collaborators

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.lead sponsor

Mapped research locations

ShanghaiChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07697586 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.